Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
New York Presbyterian Brooklyn Methodist Hospital
The investigators hypothesize that the PEP-FV used as adjunctive therapy in patients hospitalized for an acute exacerbation of COPD will result in decreased hospital length of stay and improvement of overall COPD-related health outcomes.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Admitted with COPD exacerbation as a primary diagnosis
Subjectively produces more than 1 tablespoon (15 ml) / day of sputum
Has the subjective feeling that he/she cannot cough up or clear her secretions
Physical respiratory system exam by the physician with evidence of course ronchi suggestive of impacted secretions
\> 10 pack-year smoking history
You may not be if
Cannot use the flutter device or unable to follow commands
Altered mental status
Known active malignancy
Known systolic congestive heart failure (CHF) with ejection fraction (EF) \< 40% or clinically in acute CHF exacerbation as documented by cardiologist or primary diagnosis other than COPD
Pregnancy
Patients in severe exacerbation (Intubated, Continuous use of NIPPV, Unable to speak full sentences)
